Cited by 165Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology ResearchAutism Spectrum Disorder Research

The DOI matches its Crossref record; 68 of the 84 references it cites were found in a registry or an index, and 16 are not checked yet; 2 of the 39 sources its claims cite were checked for support.

Genetic Reduction of Matrix Metalloproteinase-9 Promotes Formation of Perineuronal Nets Around Parvalbumin-Expressing Interneurons and Normalizes Auditory Cortex Responses in Developing Fmr1 Knock-Out Mice

Open access

Abstract

Abnormal sensory responses associated with Fragile X Syndrome (FXS) and autism spectrum disorders include hypersensitivity and impaired habituation to repeated stimuli. Similar sensory deficits are also observed in adult Fmr1 knock-out (KO) mice and are reversed by genetic deletion of Matrix Metalloproteinase-9 (MMP-9) through yet unknown mechanisms. Here we present new evidence that impaired development of parvalbumin (PV)-expressing inhibitory interneurons may underlie hyper-responsiveness in auditory cortex of Fmr1 KO mice via MMP-9-dependent regulation of perineuronal nets (PNNs). First, we found that PV cell development and PNN formation around GABAergic interneurons were impaired in developing auditory cortex of Fmr1 KO mice. Second, MMP-9 levels were elevated in P12-P18 auditory cortex of Fmr1 KO mice and genetic reduction of MMP-9 to WT levels restored the formation of PNNs around PV cells. Third, in vivo single-unit recordings from auditory cortex neurons showed enhanced spontaneous and sound-driven responses in developing Fmr1 KO mice, which were normalized following genetic reduction of MMP-9. These findings indicate that elevated MMP-9 levels contribute to the development of sensory hypersensitivity by influencing formation of PNNs around PV interneurons suggesting MMP-9 as a new therapeutic target to reduce sensory deficits in FXS and potentially other autism spectrum disorders.

Verified 2026-10-06 · 16 references not checked yet

Overview

Integrity signals

Registry

Crossref · 10.1093/cercor/bhx258

Cites

68 of 84 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

49 Own result · 23 Not checked yet · 13 Own interpretation · 10 Own method · 1 Supported · 1 No basis given

Verify all 37 references — free account
  • It may state two separate claims as one. 43
  • Probably not a substantial claim. 17
  • The quote only partly states this claim. 1
55 of 55
  • The paper relies on this without support.

    MMP-9 protein levels measured by gelatin zymography reflect MMP-9 enzymatic activity in vivo.

    “Levels of MMP-2 and MMP-9 proteins were quantified by densitometry using Image J.”
  • The paper relies on this without support.

    Genetic reduction of MMP-9 in Mmp9+/- Fmr1 knock-out mice does not cause compensatory changes that independently affect PNN formation or auditory responses.

    “The FVB.Cg-Mmp-9 tm1Tvu /J mice were backcrossed, in-house, with Fmr1 KO mice to generate Mmp9 +/-Fmr1 KO mice, which had only 1 allele of the Mmp9 gene and reduced expression of MMP-9.”
  • The paper relies on this without support.

    The restoration of auditory responses by MMP-9 reduction is mediated by changes in PNN formation around PV cells rather than by a direct effect of MMP-9 on neuronal excitability.

    “These data implicate MMP-9 in the development of auditory cortex hyperexcitability in Fmr1 KO mice via the regulation of PNN formation around PV interneurons and provide further support for targeting MMP-9 in treatment of FXS.”
  • The paper relies on this without support.

    Findings in mouse auditory cortex are relevant to human FXS sensory deficits.

    “These findings indicate that elevated MMP-9 levels contribute to the development of sensory hypersensitivity by influencing formation of PNNs around PV interneurons suggesting MMP-9 as a new therapeutic target to reduce sensory deficits in FXS and potentially other autism spectrum disorders.”
  • The authors state this as an assumption.

    In wild-type animals, FMRP translationally suppresses MMP-9 production.

    “In WT animals, there is normal production of FMRP, which translationally suppresses MMP-9 production, resulting in normal development and maturation of PV interneurons (white) and PNNs (black) and normal neural excitability.”
  • The authors state this as an assumption.

    In Fmr1 knockout mice, loss of FMRP leads to upregulated production of MMP-9.

    “Fmr1 KO results in loss of FMRP and upregulated production of MMP-9.”
6 of 6

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 84 references

Cited by

Sorted by citations

See all 165

Metadata

Authors
Wen, T. H., Afroz, S., Reinhard, S. M., Palacios, A. R., Tapia, K., Binder, D. K., Razak, K. A., & Ethell, I. M.
Affiliations
University of California, Riverside (US)
Corresponding author
  • Razak, Khaleel A
  • Ethell, Iryna M
Venue
Cerebral Cortex
Published
2017-10-13
Volume
28
Issue
11
Pages
3951-3964
ISSN
  • 1047-3211 (ISSN-L)
  • 1460-2199
OpenAlex
W2763626521
Cited by
165
References
84
Citations by year
2026: 13 · 2025: 20 · 2024: 23 · 2023: 15 · 2022: 18 · 2021: 27 · 2020: 24 · 2019: 17 · 2018: 8
FWCI
8.87
Type
journal article
Language
en
Open access
Locations
  • Cerebral Cortex (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Institutes of Health (NIH) (1U54 HD082008-01)
  • US Army Medical Research (W81XWH-15-1-0436)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
Keywords
fragile X syndrome, Fmr1 knockout mice, MMP-9, perineuronal nets, parvalbumin interneurons, auditory cortex, sensory hypersensitivity, autism spectrum disorder, inhibitory interneurons, auditory habituation, therapeutic target
MeSH terms
Animals, Auditory Cortex, Disease Models, Animal, Fragile X Syndrome, Interneurons, Male, Nerve Net, Parvalbumins, Mice, Knockout, Matrix Metalloproteinase 9, Fragile X Messenger Ribonucleoprotein 1, GABAergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review